ライフサイエンスコーパス: cholelithiasis

1 ause of biliary dilatation was usually (45%) cholelithiasis.

2 antiretroviral regimen developed complicated cholelithiasis.

3 The course of CDA is often complicated by cholelithiasis.

4 phy remains the most useful tool to document cholelithiasis.

5 and no participants in the placebo group had cholelithiasis.

6 and pancreas were fatty liver (20%, 44/220), cholelithiasis (14.5%, 32/220) and acute pancreatitis (0

7 d a higher incidence of gout (2.6% vs 2.0%), cholelithiasis (2.5% vs 1.1%), and increases in serum cr

8 ies observed in 84.2%, primarily obstructive cholelithiasis (22.8%) and pancreatic head masses (13.9%

9 se level, number of prior AP episodes, prior cholelithiasis, abdominal surgery within 2 months, prese

10 espect to other biliary pathology, including cholelithiasis, acute cholecystitis, and pancreatitis.

11 atients, 32 (64%) had hepatomegaly, 15 (30%) cholelithiasis and 3 (6%) biliary sludge.

12 s following both procedures were symptomatic cholelithiasis and abdominal pain of unknown origin.

13 Fifty-three patients with cholelithiasis and biliary colic were enrolled in this r

14 y is the procedure of choice for symptomatic cholelithiasis and biliary dyskinesia.

15 In this study, hepatomegaly, cholelithiasis and biliary sludge were the most common h

16 cosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L:

17 irculating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlig

18 Though cholelithiasis and cholecystitis are common clinical pro

19 hernia, marginal ulcer, biliary disease (eg, cholelithiasis and choledocholithiasis), and jejunojejun

20 analyses showed that the increased risks of cholelithiasis and GERD were more pronounced in trials i

21 RAs are associated with an increased risk of cholelithiasis and GERD, but do not appear to increase t

22 GLP-1RAs increased the risk of cholelithiasis and probably increased the risk of GERD c

23 low income, with a diagnosis of symptomatic cholelithiasis and referral for outpatient surgical cons

24 e occurred among patients with uncomplicated cholelithiasis and with elective admissions.

25 rum includes hepatic steatosis, cholestasis, cholelithiasis, and hepatic fibrosis.

26 ced fibrosis, inflammation, steatosis score, cholelithiasis, and increased serum bile acids and bilia

27 Cholecystitis and cholelithiasis are being recognized with increasing freq

28 Development and management of ATV-associated cholelithiasis are discussed.

29 ocially vulnerable patients with symptomatic cholelithiasis are more likely to face barriers to acces

30 , but increased risks of pulmonary embolism, cholelithiasis, asthma, meningioma, and thyroid, breast,

31 erence in the prevalence of hepatomegaly and cholelithiasis between the patients and controls (p valu

32 at heart transplant patients frequently have cholelithiasis, but offer no consensus about treatment s

33 Infants with cholelithiasis can be managed expectantly unless symptom

34 included trials that reported cholecystitis, cholelithiasis, cholangitis, cholestasis, pancreatitis,

35 unplanned hospitalization due to symptomatic cholelithiasis, cholecystitis, choledocholithiasis, chol

36 se) and ICC (biliary cirrhosis, cholangitis, cholelithiasis, choledochal cysts, hepatitis B virus, he

37 terohepatic Helicobacter spp and cholesterol cholelithiasis, chronic cholecystitis, and gallbladder c

38 1561 patients with symptomatic uncomplicated cholelithiasis, defined as gallstone disease without sig

39 nosed 4 months (mean) after transplantation; cholelithiasis developed in 10 of these patients (32%) w

40 The management of pediatric cholelithiasis differs between various hospitals and bet

41 scoring system for the physical chemistry of cholelithiasis during feeding of a lithogenic diet.

42 ia for selecting patients with uncomplicated cholelithiasis for cholecystectomy and rethinking laparo

43 al care for select patients with symptomatic cholelithiasis for cholecystectomy, resulted in a signif

44 underwent cholecystectomy for uncomplicated cholelithiasis from January 2021 to December 2022 were i

45 s; idiopathic chronic pancreatitis or occult cholelithiasis have been associated with 'recurrent acut

46 in the operative management of uncomplicated cholelithiasis; however, these guidelines were derived e

47 senmenger syndrome include hemoptysis, gout, cholelithiasis, hypertrophic osteoarthropathy, and decre

48 llstone disease without signs of complicated cholelithiasis (ie, biliary pancreatitis, cholangitis, c

49 llstone disease without signs of complicated cholelithiasis, ie, biliary pancreatitis, cholangitis, c

50 evaluated the German management of pediatric cholelithiasis in a dual approach.

51 urated fats act as inhibitors of cholesterol cholelithiasis in animal experiments.

52 work on genetics of experimental cholesterol cholelithiasis in inbred mice promises help in pinpointi

53 re severe cholecystitis (72.1%), followed by cholelithiasis in liver cirrhosis and portal hypertensio

54 de a feasible therapeutic concept to prevent cholelithiasis in patients at risk.

55 to identify the first episode of symptomatic cholelithiasis in patients older than 65 years who did n

56 -cutaneous fistula is a rare complication of cholelithiasis in present-day practice.

57 sceptibility and pathogenesis of cholesterol cholelithiasis in these strains of inbred mice.

58 cholecystectomy, a surrogate for symptomatic cholelithiasis, in a cohort of 60,290 women who were 40

59 ll thickness, THAD, fat in gallbladder wall, cholelithiasis, infiltration, biliary dilatation, lymph

60 Cholelithiasis is being recognized more frequently in th

61 Cholesterol cholelithiasis is common in Western populations and repr

62 ystectomy in older patients with symptomatic cholelithiasis is complicated.

63 Open questions revealed that complicated cholelithiasis is managed individually.

64 Cholesterol cholelithiasis is one of the most prevalent and most cos

65 rophylactic cholecystectomy for asymptomatic cholelithiasis is sometimes required before transplantat

66 The presence of gallstones (cholelithiasis) is a highly prevalent and severe disease

67 ntinuous or discontinuous mucosal lining and cholelithiasis may indicate XGC rather than gallbladder

68 ion obstruction, renal subcapsular hematoma, cholelithiasis, medullary calcinosis, and myelolipoma.

69 ign causes of biliary dilatation, apart from cholelithiasis, MRCP picture is often atypical and there

70 alculi (n=6), small-bowel obstruction (n=2), cholelithiasis (n=2), pyelonephritis (n=2), diaphragmati

71 Abnormal findings were cholelithiasis (n=3), obstructive hydronephrosis (n=1),

72 ve (6%) participants in the fitusiran group (cholelithiasis [n=2, 3%], cholecystitis [n=1, 1%], lower

73 M 171060) is a peculiar form of intrahepatic cholelithiasis occurring in young adults, associated wit

74 dren, occurring in 2% to 6% of children with cholelithiasis, often in association with obstructive ja

75 In the control group, one (2%) person had cholelithiasis, one (2%) biliary sludge, one (2%) fatty

76 cancer were compared with 264 controls with cholelithiasis or choledocholithiasis in the absence of

77 in patients with low-phospholipid-associated cholelithiasis or intrahepatic cholestasis of pregnancy.

78 , neutropenia, nausea, hypophosphatemia, and cholelithiasis or pancreatitis.

79 t inflammation owing to choledocholithiasis, cholelithiasis, or primary sclerosing cholangitis, but m

80 ated with males (P = 0.041), the presence of cholelithiasis (P = 0.012), but not pre-ablation chemoth

81 typhoid endemic Mexico City, 5% of enrolled cholelithiasis patients carried serovar Typhi, and bacte

82 the severity of pain and the development of cholelithiasis-related complications.

83 elief of biliary colic and the prevention of cholelithiasis-related complications.

84 d determine novel associations, notably with cholelithiasis risk.

85 usly reported (e.g., diabetes, constipation, cholelithiasis, short stature, failure to thrive).

86 ropriate antidiuretic hormone; pancreatitis; cholelithiasis; superior mesenteric artery syndrome; ile

87 The low-phospholipid-associated cholelithiasis syndrome (LPAC; OMIM 171060) is a peculia

88 socially vulnerable adults with symptomatic cholelithiasis, telemedicine consultation compared with

89 being the primary indication and obstructive cholelithiasis the most frequent diagnosis.

90 sistent treatment of pediatric patients with cholelithiasis throughout national and international dep

91 ntrast to adults, for whom guidelines on the cholelithiasis treatment exist, there is no consistent t

92 Uncomplicated cholelithiasis was defined as gallstone disease without

93 Pediatric complicated cholelithiasis was not managed acutely in the majority o

94 Management of pediatric patients with cholelithiasis was primarily performed by pediatricians

95 The incidences of gout and cholelithiasis were higher with bempedoic acid than with

96 Rates of gout and cholelithiasis were higher with bempedoic acid, and smal

97 24 hospitals with symptomatic, uncomplicated cholelithiasis were included.

98 Increased heart rate and cholelithiasis were observed more often in the liragluti

99 ign causes of biliary dilatation, apart from cholelithiasis, were identified in 16 individuals, inclu

100 In patients with cholelithiasis who present with biliary colic, a single

101 deciding whether patients with uncomplicated cholelithiasis will benefit from cholecystectomy.

102 s for novel therapies to prevent cholesterol cholelithiasis worldwide.